What are the differential diagnoses for folliculitis in a patient with chronic kidney disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differential Diagnoses for Folliculitis in CKD Patients

In a patient with chronic kidney disease presenting with folliculitis, you must systematically consider infectious causes (bacterial, fungal, viral, parasitic), drug-induced folliculitis (particularly from immunosuppressants in transplant recipients or EGFR inhibitors if on cancer therapy), acquired perforating dermatosis (strongly associated with CKD and dialysis), uremic pruritus with secondary excoriation, and less commonly calciphylaxis or other CKD-specific dermatoses.

Primary Differential Categories

1. Infectious Folliculitis

The most common cause remains Staphylococcus aureus bacterial folliculitis 1. However, in CKD patients, the differential expands significantly:

  • Bacterial: S. aureus (most common), Gram-negative organisms (Pseudomonas, Klebsiella, Proteus)
  • Fungal: Candida species, dermatophytes, Malassezia
  • Viral: Herpes simplex, varicella-zoster (especially in immunosuppressed transplant patients)
  • Parasitic: Demodex mites

Critical pitfall: CKD patients, particularly those on dialysis or post-transplant, have compromised immunity 2. Immunosuppressed transplant patients are at risk for opportunistic infections including candidiasis, and when severely immunocompromised, can develop Kaposi's sarcoma or non-Hodgkin lymphoma 2.

2. Acquired Perforating Dermatosis (APD)

This is a CKD-specific condition that frequently mimics or presents as folliculitis 3, 4:

  • Occurs in 72.7% of patients with chronic renal failure, with 50% having concurrent diabetes mellitus 3
  • All patients with CKD and APD in one study were on dialysis 3
  • Clinical presentation can resemble perforating folliculitis, reactive perforating collagenosis, or Kyrle's disease 3
  • Evolution: Early follicular pustules → perforating folliculitis → prurigo nodularis 4

Key distinguishing features: Look for umbilicated papules with central keratotic plugs, predominantly on extensor surfaces and areas of trauma. Histopathology shows transepidermal elimination of dermal material 3.

3. Drug-Induced Folliculitis

Specific medications common in CKD patients can cause folliculitis:

  • Immunosuppressants (in transplant recipients): Can cause lichenoid oral lesions and increase infection risk 2
  • EGFR inhibitors (if patient has concurrent malignancy): Cause folliculitis in 85% of patients, typically within 7-10 days of starting therapy 5
  • Corticosteroids: Can cause steroid-induced folliculitis

4. Uremic Pruritus with Secondary Changes

Pruritus affects 42% of hemodialysis patients 6:

  • Severe scratching can lead to secondary follicular inflammation and infection
  • Associated with xerosis (dry skin), which is the most common cutaneous sign in dialysis patients 6
  • May present with excoriated follicular papules rather than primary folliculitis

5. Other CKD-Specific Dermatoses to Consider

  • Calciphylaxis (calcific uremic arteriolopathy): Presents with painful violaceous plaques that can ulcerate, not typically follicular but important not to miss 7
  • Uremic frost: Rare, occurs when BUN >300 mg/dL 2
  • Porphyria cutanea tarda: Can occur in CKD patients 8, 9

Diagnostic Approach

Immediate Clinical Assessment

  1. Lesion morphology and distribution:

    • Monomorphic pustules on face/trunk → Consider infectious or drug-induced
    • Umbilicated papules with plugs on extremities → Consider APD
    • Excoriated lesions with xerosis → Consider uremic pruritus
  2. Timing relative to CKD treatment:

    • New medication within 7-10 days → Drug-induced
    • On dialysis → APD highly likely (especially if diabetic)
    • Post-transplant → Opportunistic infection
  3. Associated symptoms:

    • Severe pruritus → Uremic pruritus (check dialysis adequacy, Kt/V should be ≥1.6) 6
    • Pain out of proportion → Consider calciphylaxis

Laboratory and Diagnostic Testing

Perform cytology first - this is simple, rapid, inexpensive, and can identify bacterial, fungal, viral, and parasitic pathogens 1:

  1. Gram stain and culture from pustule
  2. KOH preparation for fungal elements
  3. Tzanck smear if viral etiology suspected
  4. Skin biopsy if diagnosis unclear or APD suspected (shows transepidermal elimination) 3

Assess CKD-related factors 6, 10:

  • Dialysis adequacy (Kt/V)
  • Calcium-phosphate balance
  • PTH levels (hyperparathyroidism contributes to pruritus)
  • Hemoglobin (anemia common in CKD)
  • Immunosuppression status if transplant recipient

Management Considerations

For Infectious Folliculitis

  • Avoid empiric antibacterial treatment without confirmation - this leads to months/years of inappropriate therapy 1
  • Culture-directed therapy based on cytology/culture results
  • Consider anti-staphylococcal antibiotics (doxycycline, minocycline) if S. aureus confirmed 4

For Acquired Perforating Dermatosis

Combined approach proved effective 4:

  • Oral anti-staphylococcal antibiotic
  • Phototherapy
  • Topical corticosteroid lotion
  • Optimize dialysis adequacy

For Uremic Pruritus-Related Changes

  • Ensure adequate dialysis (Kt/V ≥1.6) 6
  • Normalize calcium-phosphate balance
  • Control PTH levels
  • Essential: Aggressive emollient use for xerosis 6
  • Consider topical capsaicin 0.025% cream four times daily 6

Critical caveat: In CKD patients, always check renal function before prescribing systemic medications and adjust doses appropriately. Avoid nephrotoxic agents 11.

References

Research

First step in the differential diagnosis of folliculitis: cytology.

Critical reviews in microbiology, 2013

Research

Acquired perforating dermatosis: clinicopathological features in twenty-two cases.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2006

Research

Part I. Dermatologic Manifestations in Patients with Kidney Disease.

Journal of the American Academy of Dermatology, 2025

Research

Skin manifestations of chronic kidney disease.

Actas dermo-sifiliograficas, 2015

Research

KDIGO 2024 clinical practice guideline on evaluation and management of chronic kidney disease: A primer on what pharmacists need to know.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.